Skip to content

Prospective cohort study of synovial biomarkers in the diagnosis and prediction of periprosthetic joint infection

Prospective cohort study of synovial biomarkers in the diagnosis and prediction of periprosthetic joint infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400086813
Enrollment
Unknown
Registered
2024-07-11
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periprosthetic joint infection

Interventions

Infection group: Joint puncture to extract joint fluid:None
None infection group: Joint puncture to extract joint fluid:None

Sponsors

The first affliated hospital, Xinjiang medical university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Age =18 years old, gender is not limited; (2) The experimental group met the diagnostic criteria of chronic periprosthesis infection after joint replacement according to the 2018 Musculoskeletal Infection Association; The control group was eligible for primary replacement patients who excluded periprosthesis infection. (3) Voluntary and signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with immune-related arthritis such as rheumatoid and rheumatism were excluded; (2) Radiotherapy and chemotherapy are required due to neoplastic diseases; (3) Receiving systemic glucocorticoid therapy (prednisone > 10mg/ day or equivalent hormone medication); (4) Severe immunodeficiency diseases (such as stage 3 HIV, sickle cell anemia, splenectomy, etc.); (5) Have a history of drug abuse; (6) Use immunosuppressive drugs to treat bone marrow or other transplants; (7) Pregnant, parturient and lactating women; (8) Participating in other clinical trials; (9) Researchers consider other reasons not appropriate for clinical trial participants.

Design outcomes

Primary

MeasureTime frame
Joint fluid target protein detection;

Secondary

MeasureTime frame
X-ray;Hip and knee function score;Liver function;Kidney function;Erythrocyte sedimentation rate (ESR);C-reactive protein (CRP);Synovial fluid white blood cell count (WBC);Synovial fluid polymorphycyte neuclear cell (PMN)%;Doppler lower extremity vascular color ultrasound;Infection control rate;Time between infection recurrence;Re-operation rate;Type of antibiotic;

Countries

China

Contacts

Public ContactBoyong Xu

Department of Joint Surgery, The First Affiliated Hospital, Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, People 's Republic of China

1031181455@qq.com+86 132 0126 3027

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026